Cancer BiologybioRxivPreprint
Machine Learning-Driven Discovery of Synergistic Protein Interactions Identifies ATL3 as a Putative Biomarker for Cancer Drug Response
Priya Ramarao-Milne, Anubhav Kaphle, Roc Reguant…·Denis C. Bauer
The paper introduces synerOmics, a machine learning framework to identify synergistic protein interactions, finding ATL3 as a biomarker for lapatinib resistance in breast cancer.
DOI 10.1101/2025.11.05.686871